BRIEF-Taysha Gene Therapies Q1 Net Income USD -21.529 Million Vs. IBES Estimate USD -22.6 Million

Reuters
15 May
BRIEF-Taysha Gene Therapies Q1 Net Income USD -21.529 Million Vs. IBES Estimate USD -22.6 Million

May 15 (Reuters) - Taysha Gene Therapies Q1 operating expenses USD 23.723 million.

  • Q1 basic EPS USD -0.08
  • Q1 operating income USD -21.421 million vs. IBES estimate USD -22.9 million
  • Q1 EPS USD -0.08 vs. IBES estimate USD -0.09

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10